BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

LFSCvsARKGETF Comparison

ETF 1

LFSC

F/m Emerald Life Sciences Innovation ETF

This fund is part of

Life Sciences

+0.39%

Full LFSC fund page

VS

ETF 2

ARKG

ARK Genomic Revolution ETF

This fund is part of

BioTech & Genomics

-0.01%

Full ARKG fund page

F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. LFSC's top 3 sector exposures are Health Care and Sovereign. In contrast, ARKG's top sector exposures are Health Care and Information Technology. LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.75% for ARKG. LFSC is up 4.23% year-to-date (YTD) with +$5M in YTD flows. ARKG performs worse with -2.36% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of LFSC and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

LFSC vs ARKG performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 05/01/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	LFSC ARKG	+9.29%+14.98%	+4.98%-9.13%	+4.23%-2.36%	+64.72%+27.92%	n/a-2.43%	n/a-67.96%
Flows	LFSC ARKG	+$81K-$2M	+$6M-$53M	+$5M-$17M	+$15M-$66M	--$583M	--$3.03B

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	LFSC ARKG	+28.86%+43.08%	+26.32%+41.66%	n/a+42.62%	n/a+45.37%
Max drawdown	LFSC ARKG	-10.65%-20.97%	-16.25%-27.52%	n/a-51.98%	n/a-80.16%
Max drawdown duration	LFSC ARKG	47d90d	142d97d	n/a1015d	n/a1765d

Trading data

Create an account to view trading data

Join for free

	LFSC	ARKG
Last sale 5/1/2026 at 1:30 PM	$38.15	$30.30
Previous close 04/29/2026	$38.03	$29.87
Consolidated volume 04/29/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Main metrics

Last update 5/1/2026 at 1:30 PM

Live

Closed

	LFSC	ARKG
Last price	$38.15	$30.30
1D performance	+0.34%	+1.44%
AuM	$101.77 M	$1.13 B
E/R	0.79%	0.75%

Characteristics

	LFSC	ARKG
Management strategy	Active	Active
Provider	Emerald Group	Ark Investment
Benchmark	-	-
N° of holdings	33	27
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	October 31, 2024	April 2, 2019
ESG	No	No

More LFSC data on Trackinsight

More ARKG data on Trackinsight

Exposure

Countries

LFSC

USA

90.82%

United Kingdom

7.06%

Other

2.12%

ARKG

USA

70.4%

Switzerland

9.23%

Other

20.37%

Sectors

LFSC

Health Care

78.16%

Other

21.84%

ARKG

Health Care

78.38%

Other

21.62%

Diversification

LFSC

Total weight of top 15 holdings out of 15

69.28%

ARKG

Total weight of top 15 holdings out of 15

62.5%

Top 15 holdings

Data as of March 31, 2026

LFSC

COGENT BIOSCIENCES

9.11%

LIVANOVA

7.06%

UTD THERAPEUT

5.61%

US00773J2024

5.14%

MIRUM PHARMACEUTICALS INC

5.09%

TRAVERE THERAPEUTICS INC

4.75%

KALVISTA PHARMACEUTICALS INC

4.74%

GUARDANT HEALTH INC

4.38%

BRIDGEBIO PHARMA

4.05%

US6402683063

3.78%

TRANSMEDICS GROUP

3.77%

SAVARA INC

3.74%

TREVI THERAPEUTICS

2.95%

ICU MEDICAL

2.79%

AXSOME THERA CMN STK

2.32%

ARKG

CRISPR THERAPEUTICS

9.23%

10X GENOMICS INC

6.30%

BEAM THERAPEUTICS

4.86%

PERSONALIS INC

4.69%

NATERA

4.48%

ILLUMINA

4.45%

GUARDANT HEALTH INC

4.21%

INTELLIA THERAPEUTICS INC

3.58%

CAREDX INC/D

3.56%

RECURSION PHARMACEUTICALS

3.54%

ABSCI

3.27%

VERACYTE INC/D

2.98%

ADAPTIVE BIOTECHNOLOGIES

2.71%

NURIX THERAPEUTICS

2.45%

SEMA4 HOLDINGS CORP

2.19%

Frequently asked questions about LFSC and ARKG

How have the LFSC and ARKG ETFs performed in 2026?

As of May 1, 2026, LFSC is up 4.23% year-to-date (YTD), while ARKG has lost -2.36%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: LFSC or ARKG?

Year-to-date, the LFSC ETF saw +$5M in flows, compared to -$17M for ARKG.

Which ETF is more volatile: LFSC or ARKG?

Over the past year, LFSC had a volatility of 26.32%, while ARKG experienced 41.66%.

Which ETF is bigger: LFSC or ARKG?

As of May 1, 2026, LFSC holds $101.77 M in assets under management (AUM), while ARKG manages $1.13 B.

What sectors do the LFSC and ARKG ETFs invest in?

LFSC leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.

What are the top holdings of the LFSC ETF and ARKG ETF?

LFSC top holdings include COGENT BIOSCIENCES, LIVANOVA and UTD THERAPEUT. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS.

Which ETF is more diversified: LFSC or ARKG?

LFSC holds 44 securities with 69.28% of its assets in the top 15. ARKG has 27 securities and a top 15 weight of 62.5%.

Biotech ETFs – Investing in Health Innovation

July 21, 2022

ARKG

LFSCvsARKGETF Comparison

F/m Emerald Life Sciences Innovation ETF

ARK Genomic Revolution ETF

LFSC vs ARKG performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the LFSC and ARKG ETFs performed in 2026?

As of May 1, 2026, LFSC is up 4.23% year-to-date (YTD), while ARKG has lost -2.36%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: LFSC or ARKG?

Year-to-date, the LFSC ETF saw +$5M in flows, compared to -$17M for ARKG.

Which ETF is more volatile: LFSC or ARKG?

Over the past year, LFSC had a volatility of 26.32%, while ARKG experienced 41.66%.

Which ETF is bigger: LFSC or ARKG?

As of May 1, 2026, LFSC holds $101.77 M in assets under management (AUM), while ARKG manages $1.13 B.

What sectors do the LFSC and ARKG ETFs invest in?

LFSC leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.

What are the top holdings of the LFSC ETF and ARKG ETF?

LFSC top holdings include COGENT BIOSCIENCES, LIVANOVA and UTD THERAPEUT. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS.

Which ETF is more diversified: LFSC or ARKG?

LFSC holds 44 securities with 69.28% of its assets in the top 15. ARKG has 27 securities and a top 15 weight of 62.5%.

Biotech ETFs – Investing in Health Innovation

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up